OAZ1
OAZ1 (ornithine decarboxylase antizyme 1, also known as AZI, AZ1 and OAZ) is a negative regulator of ornithine decarboxylase and of polyamine biosynthesis and uptake. It acts as part of an auto-regulatory circuit that responds to intracellular polyamine levels. Browse Assay Genie's current range of OAZ1 research reagents below, or read on for the biology behind the target.
OAZ1 is an ornithine decarboxylase (ODC) antizyme that negatively regulates ODC activity and intracellular polyamine biosynthesis and uptake in response to rising polyamine levels. It binds ODC monomers, preventing assembly of the functional ODC homodimer, and targets the monomers for ubiquitin-independent proteolytic destruction by the 26S proteasome. It does this by inducing exposure of a cryptic proteasome-interacting surface on ODC. OAZ1 also inhibits cellular polyamine uptake by inactivating the polyamine uptake transporter.
Beyond ODC, the OAZ1 protein stabilises AZIN2 by interfering with its ubiquitination, and is involved in moving AZIN2 from the ER-Golgi intermediate compartment (ERGIC) to the cytosol. A SMAD1/OAZ1/PSMB4 complex mediates degradation of SNIP1, a repressor of CREBBP/EP300. The OAZ1 gene belongs to the ornithine decarboxylase antizyme family and encodes antizyme 1, the first member of that family, which has a broad tissue distribution. Through its control of polyamine levels it plays a role in cell growth and proliferation.
Antizyme expression depends on +1 ribosomal frameshifting, which is enhanced by high polyamine levels. The antizyme then binds and inhibits ODC, the key enzyme in polyamine biosynthesis, completing the auto-regulatory circuit. The antizyme 1 mRNA contains two potential in-frame AUGs. Studies in rat suggest that alternative use of these initiation sites gives N-terminally distinct isoforms with different subcellular localisation. Alternatively spliced transcript variants have also been noted. Mouse and rat both carry an Oaz1 ortholog.
OAZ1 limits polyamine biosynthesis and uptake in response to polyamine levels, making it central to studies of intracellular polyamine homeostasis.
OAZ1 targets ODC monomers to the 26S proteasome without ubiquitin, a useful model for ubiquitin-independent protein turnover.
Antizyme expression requires +1 ribosomal frameshifting enhanced by polyamines, so OAZ1 is a key example of regulated recoding.
By controlling polyamine levels through ODC inhibition, OAZ1 is relevant to research on cell growth and proliferation.
OAZ1 negatively regulates ornithine decarboxylase (ODC). It binds ODC monomers, blocks formation of the active homodimer and targets them to the 26S proteasome for ubiquitin-independent degradation. It also inhibits polyamine uptake, lowering intracellular polyamine levels.
OAZ1 is also known as AZI, AZ1, OAZ, MGC138338 and antizyme 1. The mRNA has two potential in-frame start codons, and rat studies suggest alternative use gives N-terminally distinct isoforms with different localisation. Alternatively spliced transcript variants have also been noted.
Yes. Mouse and rat both have an ortholog named Oaz1, and the protein belongs to the ODC antizyme family. Isoform localisation studies were carried out in rat. Check the datasheet of any product for its validated reactivity.
Polyamine-pathway proteins, antizyme partners and proteasome-related targets connected to OAZ1 function.
Gene and protein annotations from HGNC, NCBI Gene and UniProt P54368; product specifications from Assay Genie datasheets.